semaglutide death Comparison of or Dulaglutide Versus Empagliflozin for Risk for and Cardiovascular Outcomes Among Patients With Type 2 Diabetes: Two Target Trial Emulation Studies: Annals of Internal Medicine: Vol 178, No 7 GLP-1 Drugs Lower Risk of

However, keeping a close watch on symptoms and following medical advice helps prevent small problems from becoming serious

Researchers are increasingly developing therapies that target multiple biological systems involved in hunger, metabolism, insulin regulation, and energy expenditure

Retatrutide (LY3437943): This is a formidable research peptide, a novel agonist for three key receptors: the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors

Where appropriate, cognitive behavioural therapy can help to control impulsive eating behaviours, while bariatric surgeries or injectable weight loss drugs might be recommended in urgent cases 13

, , 2